EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma

Julie Giraud, Lornella Seeneevassen, Benoit Rousseau, Damien Bouriez, Elodie Sifré, Alban Giese, Tra Ly Nguyen, Camille Tiffon, Yannick Lippi, Lamia Azzi-Martin, Julie Pannequin, Armelle Ménard und 8 weitere

Gastric Cancer · 2023-03 · 26 (2) · 234-249

DOI: 10.1007/s10120-022-01357-y ↗

Kurz gefasst

Fachartikel in der Zeitschrift Gastric Cancer, online erschienen am 18.12.2022. Verfasst von Julie Giraud und 19 weiteren Autor:innen. Beteiligte Einrichtung: INSERM U1312, Bordeaux Institute of Oncology, University of Bordeaux, 146 rue Leo Saignat, 33076, Bordeaux, France. Hauptthemen laut MEDLINE: Stomach Neoplasms, Carcinoma. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Institut National Du Cancer, Ligue Contre le Cancer.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cancer stem cells (CSCs) are at the origin of tumour initiation and progression in gastric adenocarcinoma (GC). However, markers of metastasis-initiating cells remain unidentified in GC. In this study, we characterized CD44 variants expressed in GC and evaluated the tumorigenic and metastatic properties of CD44v3+ cells and their clinical significance in GC patients.

Methods

Using GC cell lines and patient-derived xenografts, we evaluated CD44+ and CD44v3+ GC cells molecular signature and their tumorigenic, chemoresistance, invasive and metastatic properties, and expression in patients-derived tissues.

Results

CD44v3+ cells, which represented a subpopulation of CD44+ cells, were detected in advanced preneoplastic lesions and presented CSCs chemoresistance and tumorigenic properties in vitro and in vivo. Molecular and functional analyses revealed two subpopulations of gastric CSCs: CD44v3+ CSCs with an epithelial-mesenchymal transition (EMT)-like signature, and CD44+/v3– CSCs with an epithelial-like signature; both were tumorigenic but CD44v3+ cells showed higher invasive and metastatic properties in vivo. CD44v3+ cells detected in the primary tumours of GC patients were associated with a worse prognosis.

Conclusion

CD44v3 is a marker of a subpopulation of CSCs with metastatic properties in GC. The identification of metastasis-initiating cells in GC represents a major advance for further development of anti-metastatic therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsCarcinomaHumansNeoplastic Stem CellsHyaluronan ReceptorsEpithelial-Mesenchymal Transition

Stichwörter der Autor:innen

CD44 variantCancer stem cellsEpithelial-mesenchymal transitionGastric cancerMetastasis initiating cells

Substanzen

Hyaluronan Receptors

Autor:innen und Institutionen

  • INSERM U1312, Bordeaux Institute of Oncology, University of Bordeaux, 146 rue Leo Saignat, 33076, Bordeaux, France.
  • Animal Facility, University of Bordeaux, 33076, Bordeaux, France.
  • Department of Digestive Surgery, Haut-Lévêque Hospital, 33000, Bordeaux, France.
  • CHU Bordeaux, 33076, Bordeaux, France.
  • Toxalim Research Centre in Food Toxicology, Université de Toulouse, INRAE, ENVT, INP-Purpan, UPS, Toulouse, France.
  • IGF, University of Montpellier, CNRS, INSERM, Montpellier, France.

ORCID-Profile: Christine Varon

Förderung

  • Institut National Du Cancer
  • Ligue Contre le Cancer

Zitieren

APA

Giraud, J., Seeneevassen, L., Rousseau, B., Bouriez, D., Sifré, E., Giese, A., Nguyen, T. L., Tiffon, C., Lippi, Y., Azzi-Martin, L., Pannequin, J., Ménard, A., Bessède, E., Staedel, C., Mégraud, F., Belleannée, G., Lehours, P., Gronnier, C., Dubus, P., & Varon, C. (2023). CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma. Gastric Cancer, 26(2), 234-249. https://doi.org/10.1007/s10120-022-01357-y

Vancouver

Giraud J, Seeneevassen L, Rousseau B, Bouriez D, Sifré E, Giese A, et al. CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma. Gastric Cancer. 2023;26(2):234-249. doi:10.1007/s10120-022-01357-y

BibTeX
@article{Giraud2023,
  author = {Giraud, Julie and Seeneevassen, Lornella and Rousseau, Benoit and Bouriez, Damien and Sifré, Elodie and Giese, Alban and Nguyen, Tra Ly and Tiffon, Camille and Lippi, Yannick and Azzi-Martin, Lamia and Pannequin, Julie and Ménard, Armelle and Bessède, Emilie and Staedel, Cathy and Mégraud, Francis and Belleannée, Geneviève and Lehours, Philippe and Gronnier, Caroline and Dubus, Pierre and Varon, Christine},
  title = {CD44v3 is a marker of invasive cancer stem cells driving metastasis in gastric carcinoma},
  journal = {Gastric Cancer},
  year = {2023},
  volume = {26},
  number = {2},
  pages = {234--249},
  doi = {10.1007/s10120-022-01357-y}
}
Kostenlos starten →